Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Proshares Trust (ZBIO) Other Non Operating Income (2023 - 2025)

Historic Other Non Operating Income for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to $1.1 million.

  • Zenas BioPharma's Other Non Operating Income fell 5454.16% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year increase of 10001.81%. This contributed to the annual value of $8.2 million for FY2024, which is 121009.62% up from last year.
  • Zenas BioPharma's Other Non Operating Income amounted to $1.1 million in Q3 2025, which was down 5454.16% from $3.0 million recorded in Q2 2025.
  • In the past 5 years, Zenas BioPharma's Other Non Operating Income registered a high of $3.6 million during Q1 2025, and its lowest value of -$16000.0 during Q3 2023.
  • In the last 3 years, Zenas BioPharma's Other Non Operating Income had a median value of $1.9 million in 2024 and averaged $1.8 million.
  • As far as peak fluctuations go, Zenas BioPharma's Other Non Operating Income skyrocketed by 1496250.0% in 2024, and later crashed by 5454.16% in 2025.
  • Over the past 3 years, Zenas BioPharma's Other Non Operating Income (Quarter) stood at $793000.0 in 2023, then skyrocketed by 334.8% to $3.4 million in 2024, then crashed by 68.65% to $1.1 million in 2025.
  • Its Other Non Operating Income was $1.1 million in Q3 2025, compared to $3.0 million in Q2 2025 and $3.6 million in Q1 2025.